Two Indian nationals were charged in connection with counterfeit Ozempic pens that spurred a December 2023 public warning from the FDA. According to court documents, from at least July 2023 to April ...

The U.S. Food and Drug Administration (FDA) has proposed restricting three GLP-1 drugs, semaglutide, tirzepatide, and liraglutide, from the 503B bulks list, which would prevent outsourcing facilities ...

United States District Court Northern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Jennifer Stechkober Filed July 2026 Read the document.

United States District CourtNorthern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Matthew Kawa Filed July 2026 Read the document.

Document Tags: 3:25-cr-00091-CCB-SJF, PDL Indiana, PDL Matthew Kawa, PDL Paradigm Peptides, PDL Peptides, PDL research drugs, PDL smuggling, judgment Return to library United States District Court ...

United States District Court Middle District of Florida USA v Swapnadip Roy and Vicky Ramancha Indictment Filed September 2025 Read the document.

Price cap proposals, like upper payment limits currently being debated by prescription drug affordability boards (PDABs) and Medicare maximum fair prices (MFPs), often assume a simple drug/price ...

Our latest analysis of FDA import records shows a continuation of the troubling patterns we’ve been documenting since February. From September 1 to October 31, 2025, large-scale freight fraud ...

United States District Court Northern District of Indiana USA v Matthew Kawa, et al Plea agreement, Jennifer Stechkober Filed October 2025 Read the document.

The peptide landscape is moving at lightning speed. Following HHS Secretary Robert F. Kennedy Jr.’s vocal criticism of the FDA's compounding rules, the agency recently removed several highly popular, ...

Document Tags: 3:25-cr-00091-CCB-SJF, PDL Indiana, PDL Jennifer Stechkober, PDL Matthew Kawa, PDL Paradigm Peptides, PDL Peptides, PDL research drugs, PDL smuggling, information Return to library ...